Breast lesion localization methods are invasive or non-invasive techniques used to observe if lesions are palpable or non-palpable, as part of diagnosis of breast cancer. There are various types of breast lesion localization methods used globally to detect the abnormalities in terms of a lump or tumor in the breasts. Rampant increase in number of women opting for preventive screening tests for breast cancer creates a highly conducive environment for growth of the Global Breast Lesion Localization Methods Market in the foreseeable future. Among various methods under breast lesion localization methods, radio occult localization lesion localization (ROLL) method is one of the fastest growing segments in terms of revenue share, which in turn is expected to underpin growth of the breast lesion localization methods market in the near future. ROLL is a precise method for early detection of breasts lesion, which includes three-dimensional localization of impalpable breast tumor in the body. It provides a unique advantage of high feasibility in connection with sentinel node biopsy in the same setting.

Market Dynamics

Rapid strides made in technology and keen interest of healthcare providers to integrate cutting-edge solutions backed up by supportive government norms is fueling growth of this highly lucrative market, especially in developed regions. Furthermore, rise in prevalence of breast cancer globally, especially in Asia Pacific countries would inadvertently support market growth in the near future. In order to alleviate this spike in incidence rate of the malady, governments are focusing on strengthening the healthcare infrastructure through supportive regulatory norms and investments. Government and non-government organizations are actively focusing on developing awareness programs regarding breast cancer. Such initiatives are projected to bring about a rapid shift in market dynamics, with Asia Pacific taking on the mantle from North America to emerge as the largest market for breast lesion localization methods. According to The Economist Intelligence Unit Limited, in 2016, China had a comparatively low breast cancer burden by world standards, with 2012 age standardized ratio for incidence and mortality around 22.1 and 5.4 per 100,000 respectively. However, in India breast cancer incidence by global standards in 2012 age standardized ratio was around 25.8 per 100,000. Despite what the statistics tend to suggest, the extent of the disease has surged significantly unlike the steady rise as estimated earlier in 2009.

Breast cancer is a condition characterized by an uncontrolled multiplication of breast cells that form a lump, which may be malignant or non-malignant in nature. Such cells usually form tumors that can often be observed on an x-ray or felt as a lump. Breast cancer occurs most commonly among women aged 40 years and above along with a small percentage of men affected by the same. A novel technique of radio occult lesion localization is currently used for detection of non-palpable suspicious breast lesion, which is one of the latest techniques that is expected to gain major traction and in turn fuel growth of the global breast lesion localization methods market over the forecast period (2016–2024). Breast screening programs are favoring early detection of breast cancer, which is further supporting their appropriate treatment with novel techniques. According to Department of Oncology, part of Oxford University, in 2007, around 25% of the cancers were non-palpable that needed specific treatment such as radio-guided occult lesion localization.

Ask For Sample Copy Of This Report : https://www.coherentmarketinsights.com/insight/request-sample/104

Favorable reimbursement policies favoring growth of the breast lesion localization methods market in developed regions

Favorable reimbursement scenario in several developed countries, especially North America further favors growth in research related to finding novel technique to detect cancer. According to American Cancer Society, one time screening mammogram every 12 months is covered fully under Medicare for all women aged 40 and older. Also, it pays for clinical breast exam (CBE) in every 24 months once, for women with average risk of breast cancer. This in turn is expected to increase in rate of breast cancer screening with subsequent increase in growth for breast lesion localization methods market in the near future.

Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at [email protected]

https://www.coherentmarketinsights.com/phase-xs/

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]